Mucolytics useful for COPD, guidelines say

doi:10.1136/bmj.328.7438.486-d

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Caroline White

London

Doctors need to be much more aware of the possibility of chronic obstructive pulmonary disease (COPD), particularly among current and former smokers, new clinical guidelines say.

Half of the estimated 1.5 million people in the United Kingdom with the disease remain undiagnosed. It is the fifth commonest cause of death in England and Wales, accounting for nearly 28 000 deaths every year.

The guidelines were developed for the National Institute for Clinical Excellence (NICE) by the National Collaborating Centre for Chronic Conditions, to raise standards of care for …